Wake Forest University Health Sciences, North Carolina
Dr. Ryan Maves is a Professor of Medicine at the Wake Forest University School of Medicine in Winston-Salem, North Carolina, where he serves as a faculty intensivist and infectious diseases specialist at Wake Forest Baptist Medical Center. A graduate of the University of Washington School of Medicine, he completed his internal medicine residency and fellowships in infectious diseases and critical care at the Naval Medical Center in San Diego, California. Following fellowship, he served at the Naval Medical Research Unit No.6 in Lima, Peru, leading studies in antimicrobial drug resistance and vaccine development. He returned to NMCSD in 2010, serving as ID division head. In 2012, Dr Maves deployed to the NATO Role 3 Multinational Medical Unit at Kandahar Airfield, Afghanistan, serving as Director of Medical Services. After returning from deployment, he later served as vice chair of medicine and ID fellowship program director. He retired from the United States Navy with the rank of Captain in 2021 after 22 years of active-duty service and joined the faculty at Wake Forest.
Tuesday, March 24, 2026
8:00 AM - 8:45 AM Central Time
Disclosure information not submitted.
Ethical Dilemmas in the Unrepresented Patient
Tuesday, March 24, 2026
11:00 AM - 12:00 PM Central Time
Disclosure(s): AiCuris: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); Biotest AG: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); GeoVax: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Terminated, October 20, 2024); Merck: Clinical Trial Investigator (Terminated, June 1, 2025), Grant/Research Support (Terminated, June 1, 2025); Shionogi: Advisory Board (Ongoing)
Tuesday, March 24, 2026
1:30 PM - 2:15 PM Central Time
Disclosure(s): AiCuris: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); Biotest AG: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); GeoVax: Clinical Trial Investigator (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKline: Consultant (Terminated, October 20, 2024); Merck: Clinical Trial Investigator (Terminated, June 1, 2025), Grant/Research Support (Terminated, June 1, 2025); Shionogi: Advisory Board (Ongoing)